Babson Life Sciences Entrepreneurial Product Development Immersion for New Technologies and Solutions (Babson L-SPRINT) Program
巴布森生命科学创业产品开发沉浸式新技术和解决方案 (Babson L-SPRINT) 计划
基本信息
- 批准号:10678869
- 负责人:
- 金额:$ 31.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-15 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:Active LearningAddressBasic ScienceBiological SciencesBusinessesCommunitiesCoupledDecision MakingDevelopmentDevicesDiagnostic EquipmentDrug AddictionEconomic DevelopmentEducationEducational CurriculumElectronic MailEmerging TechnologiesEntrepreneurshipEnvironmentFacultyFutureGoalsGrowthHealthHealthcareImmersionIndividualIndustryIntellectual PropertyMarketingMechanicsMobile Health ApplicationNational Institute of Drug AbuseNeurosciencesNewsletterOrganizational CultureOutcomeParticipantPatient RecruitmentsPersonal SatisfactionPharmaceutical PreparationsPublic HealthResearchResearch PersonnelRewardsRoleScientistStructureSubstance Use DisorderTechniquesTechnologyTherapeuticThinkingTrainingUncertaintyUnited StatesUnited States National Institutes of HealthWorkcollegecommercializationcommunity buildingcurriculum developmentexperienceimprovedinnovationinterestnew technologyorganizational structureoutreachproduct developmentprogramsrecruitskill acquisitionsubstance use treatmentsymposiumtool
项目摘要
PROJECT SUMMARY
Babson Life Sciences Entrepreneurial Product Development Immersion for New
Technologies and Solutions (Babson L-SPRINT) Program
Commercialized innovations and new ventures that address certain conditions, including
ventures that address the causes, consequences, and treatment of substance use disorders
(SUDs) to improve individual and public health, are still underrepresented amongst recent
startups. Commercialization and technology-based start-ups can be challenging in an academic
environment due to varying reward structures, organizational structures and organizational
cultures. Many promising scientists are reluctant to pursue intellectual property (IP) protection
and investigate commercialization opportunities, even for unique research findings, due to a lack
of understanding of the mechanics towards productizing and commercialization.
To address these misperceptions and challenges while amplifying the potential impact that
academic scientists can make to address SUDs, the Babson Life Sciences Entrepreneurial
Product Development Immersion for New Technologies and Solutions (Babson L-SPRINT)
Program will reach scientists interested in product development and commercialization as well as
to train participants in entrepreneurial thinking that can also increase decision making, improve
their organizations and labs from within, especially since product development in the biomedical
industry is highly uncertain. The Babson L-SPRINT Program includes two aims:
Aim 1: Curriculum Development--The Babson L-SPRINT program will develop a specialized
curriculum highlighting Babson’s signature Entrepreneurial Thought & Action ® offering coupled
with customized healthcare and biomedical entrepreneurship content on addressing market
segmentation and uncertainty, commercializing emerging technologies, scaling for growth, and
biomedical community experiences. The program will use live cases, panels, and other
experiential learning techniques.
Aim 2: Courses for Skills Development--We will also develop a recruitment and outreach
strategy using an innovative omnichannel approach including direct marketing utilizing email,
relevant conferences, and via NIH NIDA newsletters and other media as available.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wiljeana Glover其他文献
Wiljeana Glover的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wiljeana Glover', 18)}}的其他基金
Babson Life Sciences Entrepreneurial Product Development Immersion for New Technologies and Solutions (Babson L-SPRINT) Program
巴布森生命科学创业产品开发沉浸式新技术和解决方案 (Babson L-SPRINT) 计划
- 批准号:
10527264 - 财政年份:2022
- 资助金额:
$ 31.62万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 31.62万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 31.62万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 31.62万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 31.62万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 31.62万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 31.62万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 31.62万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 31.62万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 31.62万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 31.62万 - 项目类别:
Research Grant